| Filed On | Filing |
|---|---|
| 24 Nov 2020 |
8-K/A: Departure/Election of Directors or Officers; Compensation; Other Events
Cambridge, MA, November 23, 2020 – Summit Therapeutics Inc. (NASDAQ: SMMT) announces that Dr. Mahkam “Maky” Zanganeh, DDS, MBA, has been appointed as Chief Operating Officer, effective immediately. Dr. Zanganeh is currently a member of t... |
Loading...